Devson Catalyst Limited has confirmed the dates for its initial public offering, which will open for subscription on July 9 and close on July 13.
The catalyst and specialty chemical products manufacturer aims to raise ₹42 crore through a combination of fresh equity and an offer for sale.
Recent debuts have shown strong initial demand, with Avience Biomedicals shares surging 90% above their issue price on their market debut earlier this week.
Final allotments are scheduled for July 14, with shares set to list on the BSE SME platform shortly thereafter.
The offering arrives as India’s small and medium enterprise (SME) IPO market continues to attract investor attention.
Recent debuts have shown strong initial demand, with Avience Biomedicals shares surging 90% above their issue price on their market debut earlier this week.
Jivial Industries is also expected to finalize its IPO allotments later this month, underscoring sustained activity in the segment.